Perlecan controls neurogenesis in the developing telencephalon.
BACKGROUND
Perlecan is a proteoglycan expressed in the basal lamina of the neuroepithelium during development. Perlecan absence does not impair basal lamina assembly, although in the 55% of the mutants early disruptions of this lamina conducts to exencephaly, impairing brain development. The rest of perlecan-null brains complete its prenatal development, maintain basal lamina continuity interrupted by some isolated ectopias, and are microcephalic. Microcephaly consists of thinner cerebral walls and underdeveloped ganglionic eminences. We have studied the mechanisms that generate brain atrophy in telencephalic areas where basal lamina is intact.


RESULTS
Brain atrophy in the absence of perlecan started in the ventral forebrain and extended to lateral and dorsal parts of the cortex in the following stages. First, the subpallial forebrain developed poorly in early perlecan-null embryos, because of a reduced cell proliferation: the number of cells in mitosis decreased since the early stages of development. This reduction resulted in a decreased tangential migration of interneurons to the cerebral cortex. Concomitant with the early hypoplasia observed in the medial ganglionic eminences, Sonic Hedgehog signal decreased in the perlecan-null floor plate basal lamina at E12.5. Second, neurogenesis in the pallial neuroepithelium was affected in perlecan deficient embryos. We found reductions of nearly 50% in the number of cells exiting the cell cycle at E12-E13. The labeling index, which was normal at this age, significantly decreased with advancing corticogenesis. Moreover, nestin+ or PCNA+ progenitors increased since E14.5, reaching up to about 150% of the proportion of PCNA+ cells in the wild-type at E17.5. Thus, labeling index reduction together with increased progenitor population, suggests that atrophy is the result of altered cell cycle progression in the cortical progenitors. Accordingly, less neurons populated the cortical plate and subplate of perlecan-null neocortex, as seen with the neuronal markers beta-tubulin and Tbr1.


CONCLUSIONS
As a component of the basal lamina, perlecan both maintains this structure and controls the response of the neuroepithelium to growth factors. Less mitotic cells in the early medial ganglionic eminences, and impaired cell cycle progression in the late neocortex, suggests insufficient recruitment and signaling by neurogenic morphogens, such as SHH or FGF2.
Girós
Amparo
A
Department of Biochemistry and Molecular Biology, Universitat de València, Burjassot, Spain. m.amparo.giros@uv.es <m.amparo.giros@uv.es>
Morante
Javier
J
Gil-Sanz
Cristina
C
Fairén
Alfonso
A
Costell
Mercedes
M
D000818:Animals; D017209:Apoptosis; D001485:Basement Membrane / Q000166:cytology / Q000196:embryology / Q000378:metabolism; D002452:Cell Count; D049109:Cell Proliferation; D053595:Embryonic Stem Cells / Q000166:cytology / Q000378:metabolism; D005260:Female; D005325:Fetal Organ Maturity; D016222:Fibroblast Growth Factor 2 / Q000235:genetics; D053823:Hedgehog Proteins / Q000235:genetics; D019812:Heparan Sulfate Proteoglycans / Q000172:deficiency / Q000235:genetics*; D007150:Immunohistochemistry; D007395:Interneurons / Q000166:cytology / Q000378:metabolism; D008297:Male; D051379:Mice; D008831:Microcephaly / Q000235:genetics; D019579:Neocortex / Q000166:cytology / Q000196:embryology / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D038081:Organogenesis; D011247:Pregnancy; D013687:Telencephalon / Q000166:cytology / Q000196:embryology* / Q000378:metabolism
D053823:Hedgehog Proteins; D019812:Heparan Sulfate Proteoglycans; C465570:Shh protein, mouse; D016222:Fibroblast Growth Factor 2; C071927:perlecan